CRFR Activators

CRFR Activators encompass a range of compounds predominantly comprising peptides and small molecules that interface with the CRFR signaling axis to augment the receptor's functional state. Corticotropin-releasing factor itself serves as a primary endogenous activator, binding to CRFR to initiate a cascade of G protein-coupled receptor signaling, pivotal in stress response modulation. Similarly, Urocortin engages CRFR with substantial affinity, precipitating an activation sequence that governs physiological responses to stress and anxiety.

While molecules like Antalarmin, CP-154,526, Astressin-B, NBI-27914, R121919, Pexacerfont, and Verucerfont are traditionally recognized as CRFR antagonists, in certain experimental paradigms, they can enact inverse agonism-this atypical activation of CRFR triggers signaling mechanisms that are typically associated with stress and anxiety regulation. Furthermore, the truncated peptide CRF(6-33) exhibits the capability to function as an antagonist or inverse agonist, depending on the context, thus activating CRFR and modulating the receptor's influence on stress response pathways.